Novabay Pharmaceuticals, INC. (NBY) SEC Filings — 2024
38 SEC filings for Novabay Pharmaceuticals, INC. (NBY) in 2024.
Filings
- NovaBay Pharmaceuticals Files 8-K — 8-K · Dec 19, 2024
- NovaBay Pharma Stockholder Meeting Vote Urgently Needed — DEFA14A · Dec 11, 2024
- NovaBay CEO Urges FOR Vote at Special Meeting — DEFA14A · Dec 9, 2024
- NovaBay Pharmaceuticals Special Meeting Adjourned — DEFA14A · Nov 26, 2024
- NovaBay Pharmaceuticals Files 8-K on Shareholder Vote & Other Events — 8-K · Nov 22, 2024
- ISS Backs NovaBay's Avenova Sale Proposals — DEFA14A · Nov 15, 2024
- NovaBay Pharmaceuticals Urges Shareholder Vote — DEFA14A · Nov 13, 2024
- NovaBay Urges Shareholders to Vote — DEFA14A · Nov 12, 2024
- Novabay Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- NovaBay Pharma Q3 2024: Focus on Financing and Divestitures — 10-Q · Nov 7, 2024
- NovaBay Pharmaceuticals Files Proxy Materials — DEFA14A · Nov 6, 2024
- NovaBay Pharmaceuticals Files DEFA14A — DEFA14A · Oct 29, 2024
- NovaBay Pharmaceuticals to be Acquired by Deerfield Management — 8-K · Oct 16, 2024
- NovaBay Pharmaceuticals Enters Material Definitive Agreement — 8-K · Sep 20, 2024
- NovaBay Pharmaceuticals Q2 2024: Warrant Offerings Detailed — 10-Q · Aug 13, 2024
- NovaBay Pharmaceuticals Files 8-K — 8-K · Jul 29, 2024
- NovaBay Pharmaceuticals Files S-1/A Amendment — S-1/A · Jul 25, 2024
- NovaBay Pharmaceuticals Files S-1/A Amendment — S-1/A · Jul 15, 2024
- NovaBay Pharmaceuticals Files 8-K Report — 8-K · Jul 11, 2024
- NovaBay Pharmaceuticals Files S-1/A Amendment — S-1/A · Jul 10, 2024
- NovaBay Pharmaceuticals Files S-1 for Stock Offering — S-1 · Jun 21, 2024
- NovaBay Pharmaceuticals Files S-1 for Stock Offering — S-1 · Jun 20, 2024
- NovaBay Pharmaceuticals Files 8-K — 8-K · Jun 14, 2024
- NovaBay Pharmaceuticals Faces Delisting Notice — 8-K · Jun 7, 2024
- NovaBay Pharmaceuticals Files 8-K/A Amendment — 8-K/A · May 31, 2024
- NovaBay Pharmaceuticals Faces Delisting Concerns — 8-K · May 29, 2024
- NovaBay Pharmaceuticals, Inc. Files 10-Q for Q1 2024 — 10-Q · May 9, 2024
- NovaBay Pharmaceuticals Files 8-K — 8-K · Apr 22, 2024
- NovaBay Pharmaceuticals Faces Delisting Notice — 8-K · Apr 19, 2024
- NovaBay Pharmaceuticals, Inc. Files DEF 14A Proxy Statement — DEF 14A · Apr 18, 2024
- NovaBay Pharmaceuticals, Inc. Files 10-K/A Amendment No. 1 for Fiscal Year Ended Dec 31, 2023 — 10-K/A · Mar 29, 2024
- NovaBay Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 26, 2024
- NovaBay Pharmaceuticals Files 8-K — 8-K · Mar 25, 2024
- NovaBay Pharmaceuticals Files 8-K — 8-K · Mar 14, 2024
- Novabay Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Novabay Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Hudson Bay Capital Trims NovaBay Stake to 4.9% — SC 13G/A · Feb 6, 2024
- NovaBay Files 8-K on Material Agreement; Details Undisclosed — 8-K · Jan 10, 2024